Search filters

List of works by Luís Lima

Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.

scientific article published on 16 November 2015

Association between FAS polymorphism and prostate cancer development

article

CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications.

scientific article

CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa.

scientific article published on 24 October 2009

Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology.

scientific article published on 9 March 2018

Common genetic polymorphisms in the ABCB1 gene are associated with risk of major depressive disorder in male Portuguese individuals.

scientific article

FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.

scientific article published on 24 June 2015

FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer.

scientific article published on 12 August 2013

Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer.

scientific article published on 12 March 2018

Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion

scientific article published on 28 March 2022

Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension

scientific article published on 12 August 2016

IL-4 and TNF-α Polymorphisms Are Associated with Risk of Multiple Superficial Tumors or Carcinoma in situ Development

article

IL6-174G > C genetic polymorphism influences antidepressant treatment outcome

scientific article

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids

scientific article published in Scientific Reports

Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?

scientific article published on 21 July 2017

P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.

scientific article

Predictive biomarkers of bacillus calmette-guérin immunotherapy response in bladder cancer: where are we now?

scientific article

Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies

scientific article

Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy

scientific article published on 24 September 2013

Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival

scientific article published in 2023

TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients

scientific article published on 31 January 2020

Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours

scientific article published on 3 February 2017

The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.

scientific article published on 16 November 2013

The role of IL18-607C>A and IL18-137G>C promoter polymorphisms in antidepressant treatment phenotypes: A preliminary report.

scientific article published on 18 March 2016

The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guérin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population

scientific article published on 13 May 2015